Literature DB >> 22689634

Preoperative scar hyperalgesia is associated with post-operative pain in women undergoing a repeat Caesarean delivery.

C M Ortner1, M Granot, P Richebé, M Cardoso, L Bollag, R Landau.   

Abstract

BACKGROUND: Over 1.4 million Caesarean deliveries are performed annually in the United States, out of which 30% are elective repeat procedures. Post-operative hyperalgesia is associated with an increased risk for persistent post-surgical pain; however, there are no data on whether residual scar hyperalgesia (SHA) from a previous Caesarean delivery (CD) persists until the next delivery. We hypothesized that residual SHA may be present in a substantial proportion of women and is associated with increased post-operative pain.
METHODS: One hundred and sixty-three women scheduled for a repeat CD under spinal anaesthesia were enrolled into the study. Mechanical temporal summation (mTS) and SHA index were measured preoperatively. SHA was considered present when the index was >0. Post-operative pain scores at 12, 24 and 48 h and wound hyperalgesia (WHA) at 48 h were recorded.
RESULTS: SHA was present in 67 women 41% with a median SHA index of 0.42 (Q (25)  = 0.25; Q (75)  = 1.1, range 0.03-4.25). Women with SHA had overall higher post-operative pain scores and SHA was correlated with preoperative mTS (r = 0.164, p < 0.05), post-operative pain severity (r = 0.25, p < 0.002) and WHA at 48 h (r = 0.608, p < 0.001). Severe pain (visual analogue pain scale-S48 ≥ 7, n = 20) was predicted with a sensitivity and specificity of 60% and 62%, respectively. Positive predictive value was 18% and negative predictive value was 92%.
CONCLUSIONS: Preoperative SHA is present in 41% of women scheduled for repeat CD and is associated with increased mTS and post-operative pain. Screening for preoperative SHA may predict women at risk for increased post-operative pain, and guide post-operative analgesia to include anti-hyperalgesic drugs.
© 2012 European Federation of International Association for the Study of Pain Chapters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689634     DOI: 10.1002/j.1532-2149.2012.00171.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  12 in total

1.  Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators.

Authors:  Kristin L Schreiber; Nantthansorn Zinboonyahgoon; K Mikayla Flowers; Valerie Hruschak; Kara G Fields; Megan E Patton; Emily Schwartz; Desiree Azizoddin; Mieke Soens; Tari King; Ann Partridge; Andrea Pusic; Mehra Golshan; Rob R Edwards
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

2.  Preoperative Serum Leptin Level Is Associated with Preoperative Pain Threshold and Postoperative Analgesic Consumption in Patients Undergoing Cesarean Section.

Authors:  Nurten Seringec Akkececi; Gozen Oksuz; Aykut Urfalioğlu; Ramazan Gunesacar; Murat Bakacak; Mahmut Arslan; Bekir Mehmet Kelleci
Journal:  Med Princ Pract       Date:  2019-04-26       Impact factor: 1.927

3.  Preoperative Psychosocial and Psychophysical Phenotypes as Predictors of Acute Pain Outcomes After Breast Surgery.

Authors:  Kristin L Schreiber; Nantthasorn Zinboonyahgoon; Xinling Xu; Tara Spivey; Tari King; Laura Dominici; Ann Partridge; Mehra Golshan; Gary Strichartz; Rob R Edwards
Journal:  J Pain       Date:  2018-11-23       Impact factor: 5.820

4.  The analgesic effect of tramadol combined with butorphanol on uterine cramping pain after repeat caesarean section: a randomized, controlled, double-blind study.

Authors:  Qin Cai; Hanlin Gong; Mingbo Fan; Wen Chen; Lun Cai
Journal:  J Anesth       Date:  2020-07-05       Impact factor: 2.078

5.  Comparison of postoperative pain between patients who underwent primary and repeated cesarean section: a prospective cohort study.

Authors:  Guangyou Duan; Guiying Yang; Jing Peng; Zhenxin Duan; Jie Li; Xianglong Tang; Hong Li
Journal:  BMC Anesthesiol       Date:  2019-10-22       Impact factor: 2.217

6.  Repeated Cesarean Delivery Predicted a Higher Risk of Inadequate Analgesia Than Primary Cesarean Delivery: A Retrospective Study with Propensity Score Match Analysis.

Authors:  Guiying Yang; Xiaohang Bao; Jing Peng; Jie Li; Guangming Yan; Sheng Jing; Hong Li; Guangyou Duan
Journal:  J Pain Res       Date:  2020-03-18       Impact factor: 3.133

7.  The effect of gestational diabetes mellitus on sufentanil consumption after cesarean section: a prospective cohort study.

Authors:  Chen Yang; Wei Lian Geng; Jianying Hu; Shaoqiang Huang
Journal:  BMC Anesthesiol       Date:  2020-01-09       Impact factor: 2.217

8.  Analgesic Effect Comparison Between Nalbuphine and Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Section.

Authors:  Shen Sun; Yundong Guo; Tingting Wang; Shaoqiang Huang
Journal:  Front Pharmacol       Date:  2020-11-16       Impact factor: 5.810

Review 9.  Behavioral, Psychological, Neurophysiological, and Neuroanatomic Determinants of Pain.

Authors:  Samantha M Meints; Robert R Edwards; Christopher Gilligan; Kristin L Schreiber
Journal:  J Bone Joint Surg Am       Date:  2020-05-20       Impact factor: 6.558

10.  Comparison of Postoperative Opioid Consumption and Pain Scores in Primary Versus Repeat Cesarean Delivery in Opioid Naïve Patients.

Authors:  Amanda Chao; Ioana Pasca; Matthew Alschuler; Jay Lee; Michelle Woodfin; Justin Pugh; Briahnna Austin; Mark Ringer; Davinder Ramsingh
Journal:  J Clin Med       Date:  2019-12-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.